UNSPSC 51172408: Aluminum hydroxide/magnesium carbonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA103. This VA Drug Class (GA103) classifies this compound as belonging to the group ALUMINUM/MAGNESIUM CONTAINING ANTACIDS.

UNSPSC 51172408 Aluminum hydroxide/magnesium carbonate (Commodity) shows minimal alignment between the code's nominal scope and actual state and local procurement activity. The recent solicitations tagged under this code encompass offender drug testing services, direct-to-manufacturer pharmaceutical programs, and generic multi-source pharmaceutical distribution—none of which constitute purchases of aluminum hydroxide or magnesium carbonate compounds. The mismatch suggests either a classification error in how opportunities are being tagged or that state and local procurement systems are applying this commodity code to pharmaceutical service categories where the chemical compounds may play an ancillary role (such as in drug screening reagents or pharmaceutical formulations) without explicit mention in the solicitation scope.

The issuing bodies include county criminal justice departments (Collin County Community Supervision and Corrections Department in Texas), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing consortia (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities in Minnesota, Oregon, and other participating jurisdictions). The geographic concentration centers on Texas and the Upper Midwest, with Texas showing two distinct opportunities as of July 2026. The Collin County RFP for offender specimen collection and drug testing services (due July 23, 2026, with an estimated contract value of $600,000 and a two-year term plus optional renewals through September 1, 2026) and the Texas HHS Commission's RFI for direct-to-manufacturer prescriptions (closed April 3, 2026) represent the most recent activity. The Minnesota cooperative purchasing RFP for generic pharmaceuticals and OTC products (due March 26, 2026, effective July 1, 2026) demonstrates multistate demand, though this code does not appear to be an accurate descriptor of the work being procured.